Classifications

• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
  • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
  • G01N33/586—Liposomes, microcapsules or cells
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
  • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
  • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
  • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
  • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2458/00—Labels used in chemical analysis of biological material
  • G01N2458/40—Rare earth chelates
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
  • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y10S435/00—Chemistry: molecular biology and microbiology
  • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive

Definitions

• the present invention relates generally to compositions useful as signal generation components in immunoassays.
• the invention relates to compositions that simultaneously provide a strong signal as well as an enhanced specificity for the analytes of interest.
• Immunoassay reagents have functionality that can be broken down into two broad components: signal generation (also known as amplification) functionality, and ligand binding functionality.
• signal generation functionality is required for detection of ligand binding to analyte
• ligand binding functionality is the specificity of the reagent for the analyte.
• the ligand binding activity is accomplished by covalently attaching ligands to the particle surface.
• Antibodies and small haptens of biological significance, such as thyroxin, are examples of common ligands.
• Flourescent and chemiluminescent compositions have been widely used in signal generation components of immunoassays.
• a typical signal generation component includes a carrier, such as a latex particle, dyed with a flurosecent or chemiluminescent composition.
• metal chelates have been widely used as fluroscent and chemiluminescent dyes because of their generally large stokes' shift, sharp emission peak and long emission wavelength.
• the metal chelates are a complex formed of a metal, such as europium, samarium, or terbium, and ligands such as thiophenetrifluorobutanedione (TTA), napthyltriflurobutanedione (NTA), and 4, 7- diphenyl-1 ,10-phenathroline (DPP) trioctyl phosphine oxide (TOPO), triphenyl phosphine oxide (TPPO).
• TTA thiophenetrifluorobutanedione
• NDA napthyltriflurobutanedione
• DPP 4, 7- diphenyl-1 ,10-phenathroline
• TOPO trioctyl phosphine oxide
• TPPO triphenyl phosphine oxide
• Some commonly used metal chelates include Eu(TTA) 3 DPP and Eu(NTA) 3 DPP.
• Dyed carriers that are used to make assay reagents must have both the capability to provide signal generation, and the chemical functionality for covalent attachment of ligands.
• the process used to attach the ligands can be critical to the quality of the specificity of the ligand binding functionality.
• the specificity of the ligands can be compromised in several ways by inappropriate choices of attachment chemistry. For example, if passive adsorption of the ligands occurs simultaneously with covalent attachment, the passively adsorbed ligands may come off of the carrier during the assay. The resulting free ligand will interfere with the assay and reduce its sensitivity. Another problem that can occur is the non-specific binding of the reagent to the other carrier, which leads to elevation of the immunoassay signal in the absence of analyte.
• Ligands are often attached to polystyrene particles through carboxy groups that are attached directly to the surface of the particles. This approach can have both of the problems described above.
• the passive adsorption and nonspecific binding problems can be avoided by introducing one or more layers of immobilized hydrogel polymers, such as an aminodextran, between the polystyrene particles and the ligands. It is important for elimination of adsorption and nonspecific binding to have a continuous layer of these hydrogel polymers.
• the coating of particles that are dyed with conventional dyes such as Eu(TTA) 3 DPP or Eu(NTA) 3 DPP typically result in coating densities of aminodextran that are significantly less than optimal for preventing non-specific binding.
• the coupling density of the aminodextran is typically reduced by 40-50% from its maximum when these dyes are added at the optimum level for the chemiluminescent response of the reagent.
• Lower levels of dye give compositions that interfere less with the aminodextran coating process, but reducing the dye content also reduces the chemiluminescence necessary for a strong signal.
• compositions of the present invention provide signal generation components having an optimal balance between the reduction of non-specific binding while allowing an improved response signal.
• a composition suitable for use as a signal generation component in an immunoassay includes a carrier having a coating of an aminodextran and dyed with a metal chelate.
• the metal chelate is present in the amount of at least 0.065 ⁇ M per milligram of carrier, and the average aminodextran coating density is at least about 45 ⁇ g per milligram of carrier.
• a composition according to another aspect of the invention includes a carrier coated with an aminodextran and with a complex incorporated therein having the formula: wherein M is a metal selected from the group consisting of europium, terbium, dysprosium, samarium, osmium and ruthenium;
• L1 is a ligand selected from the group consisting of DPP, TOPO, and TPPO; L2 comprises a ligand having the formula
• a method of detecting the presence or amount of an analyte in a test sample suspected of containing the analyte comprises performing an immunoassay using the compositions of the present invention as a signal generating component.
• FIG. 1 is a schematic illustrating the synthesis of one embodiment of a metal chelate according to the present invention.
• FIG. 2 is a schematic illustrating the synthesis of another embodiment of a metal chelate according to the present invention.
• FIG. 3 is a graphical representation of aminodextran concentration and response signal as functions of metal concentration for a prior art composition.
• FIG. 4 is a graphical representation of aminodextran concentration and response signal as functions of metal concentration for compositions according to the present invention.
• compositions of the present invention are useful as signal generation components in immunoassays.
• the compositions generally include a carrier coated with an aminodextran and have a metal chelate incorporated therein.
• the compositions provide strong response signals which allows for quantitative determinations of analytes of interest, while reducing errors caused by non-specific binding.
• Carriers suitable for the present invention include solid phase materials, typically a support or surface, that can have any one of a number of shapes, such as strip, sheet, rod, plate, well, tube, particle or bead.
• the material is usually of an organic or inorganic, swellable or non-swellable, porous or non-porous, magnetic or nonmagnetic, water-insoluble material.
• the surface can be hydrophilic or capable of being rendered hydrophilic.
• the solid support includes inorganic powders such as silica, magnesium sulfate, and alumina; natural polymeric materials, particularly cellulosic materials and materials derived from cellulose, such as fiber containing papers, e.g., filter paper, chromatographic paper, etc.; synthetic or modified naturally occurring polymers, such as nitrocellulose, cellulose acetate, polyvinylchloride, polyacrylamide, crosslinked dextran, agarose, polyacrylate, polyethylene, polypropylene, poly(4- methylbutene), polystyrene, polymethacrylate, polyethyleneterephthalate, nylon, polyvinylbutyrate, etc.; either used by themselves or in conjunction with other materials; glass available as Bioglass, ceramics, magnetic materials, metals, and the like. Natural or synthetic assemblies such as liposomes, phospholipid vesicles, and cells can also be employed.
• the carrier is a particle.
• Particle encompasses spheres, spheroids, beads and other shapes as well. Suitable particles are typically at least 20 nm and not more than about 20 ⁇ m, usually at least about 40 nm and less than 10 ⁇ m, preferably 0.1 to 10 ⁇ m, more preferably, 0.1 to 5 ⁇ m, and even more preferably 0.15 to 3 ⁇ m.
• the particle may be organic or inorganic, swellable or non-swellable, porous or non-porous, having any density, but preferably of a density approximating water, generally from about 0.7 to about 1.5 g/ml, preferably suspendible in water, and composed of material that can be transparent, partially transparent, or opaque.
• the particles may be core-and-shell particles, such as particles with a magnetic core and a hard shell coating of polymerized monomer(s).
• the particles are preferably negative charged.
• the particles are preferably solid, e.g., polymer particles, metal sols (particles comprised of a heavy metal such as, e.g., gold or silver), glass particles, silicon particles, magnetic particles, dye crystallites.
• Latex particle means a particulate water-suspendible water-insoluble polymeric material.
• the latex is frequently a substituted polyethylene such as: polystyrene-butadiene, polyacrylamide polystyrene, polystyrene with amino groups, poly-acrylic acid, polymethacrylic acid, acrylonitrile-butadiene, styrene copolymers, polyvinyl acetate- acrylate, polyvinyl pyrridine, vinyl-chloride acrylate copolymers, and the like.
• Non- crosslinked polymers of styrene and carboxylated styrene or styrene functionalized with other active groups such as amino, hydroxyl, halo and the like are preferred. Frequently, copolymers of substituted styrenes with dienes such as butadiene will be used.
• the carriers according to the present invention are coated with one or more layers layers of an aminodextran.
• An aminodextran is a derivatized glucose polymer with amino groups having a molecular weight of about 10,000 to about 2,000,000, preferably about 500,000.
• Methods of preparing aminodextrans and coating carriers are known in the art. Suitable methods are described in US 5,707,877, columns 18-20, and US 5,639,620, columns 1 21 and 22.
• aminodextran Is coated on the carrier by covalent attachment of the amino group of aminodextran to the surface carboxyl groups or other amine-reactive functional group of the carrier.
• Such a method is described in provided in commonly-assigned and copending US Ser. No. 10/220,623, filed March 6, 2000 entitled “Carriers Coated with Polysaccharides, Their Preparation and Use,” the entire disclosure of which is incorporated herein by reference.
• the aminodextran coating improves the specificity of the carrier in specific binding assays and therefore improves the sensitivity of immunoassays. It has been discovered that the metal chelate of the present invention unexpectedly allows for coating of carriers with aminodextran in the amount of at least about 45 ⁇ g per milligram of carrier in the presence of a dye concentration as high as at least 0.065 ⁇ M. According to one preferred embodiment of the present invention, the aminodextran coating is present in at least about 49 ⁇ g per milligram of carrier.
• the carrier may be coated with a second layer comprising a polysaccharide, as described in U.S. Ser. No 10/220,623.
• the polysaccharide may be covalently coupled to the aminodextran layer by amine-reactive functional groups.
• the second layer comprises dextran aldheyde.
• a metal chelate is incorporated into the carrier through a known process, such as dyeing.
• the metal chelate allows for a fluorescent or chemiluminescent signal to be detected.
• the metal chelate is chosen such that relatively higher concentrations of the metal chelate do not interfere with the binding of the aminodextran coating to the carrier.
• the metal chelate is present in the amount of at least 0.065 ⁇ M per milligram of carrier, while the aminodextran average coating density is at least about 45 ⁇ g per milligram of carrier.
• the metal chelate is present in the amount of at least 0.065 ⁇ M and less than about 0.150 ⁇ M per milligram of carrier, more preferably about 0.079 ⁇ M to about 0.150 ⁇ M per milligram of carrier, and more preferably about 0.087 ⁇ M per milligram of carrier. In another embodiment of the invention, the metal chelate is present in the amount of about 0.110 ⁇ M to about 135 ⁇ M. These concentrations of metal chelate and aminodextran have been found to provide a proper balance of response signal and component specificity for the analyte of interest.
• the metal chelate has the general formula wherein M is a metal selected from the group consisting of europium, terbium, dysprosium, samarium, osmium and ruthenium;
• L1 is a ligand selected from the group consisting of DPP, TOPO, and TPPO; L2 comprises a ligand having the formula
• Suitable electron donating groups are those that make available extra negative charge to the perfluoralkyl groups.
• the electron donating group R is selected from the group consisting of Ci to C 6 alkyls, dialkylamines, ethers, thioethers, and aryl groups.
• the metal chelates of the present invention are effective in allowing optimized amounts of amindoextran to coat the carrier because the metal chelates provide an unexpectedly stable complex relative to prior metal chelate dyes.
• the stability of the complex reduces the amount of the free metal, which is believed to inhibit the attachment of the aminodextran to the carrier.
• electron donating groups R further add to the stability of the complex by making available additional negative charge to the perfluoroalkyl groups of the ligands, thereby improving the ability of the perfluoralkyl group to bind to the metal in the complex.
• M is europium and the carrier is a latex particle.
• L2 is selected from among the following formulas:
• the ligands L2 are 2-(1',1',I 1 , 2", 2',3 ⁇ 3'- heptafluoro-4 1 , 6'-hexanedion-6'-yl)-naphthylene (NHA) and 4, 4'-bis (1",1",1",2", 2", 3", 3"- heptafluroro- 4", 6" - hexanedion-6"-yl)-o-terphenyl (BHHT).
• the metal chelate comprises Eu(NHA) 3 DPP and Eu(BHHT) 2 DPP.
• the metal chelates can be prepared by combining the metal chloride with the desired ratio of metal ligand molecules in an organic solvent and sufficient base to take up the released hydrochloric acid. Suitable syntheses are illustrated in FIGS. 1-2, respectively.
• the metal chelate dyes of the present invention have been found to allow for a higher density of aminodextran coating at relatively higher concentrations of the metal chelate dyes when compared to conventional dyes, as demonstrated in the Comparative Examples below.
• the metal chelates of the present invention generally will allow an aminodextran coating at about 45 to about 55 ⁇ g per mg beads compared to about 23 to about 35 ⁇ g per mg of bead for the conventional dyes.
• the dyes of the present invention can be present in amounts sufficient to give strong response signals as part of a signal generation component in a specific binding assay, while allowing the carrier to be coated with an aminodextran in an amount sufficient to reduce the amount of non- specific binding.
• compositions of the present invention are suitable for use as a signal generation component in specific binding assays.
• the compositions are suitable for any immunoassay in which a signal is measured in response to ligand binding to an analyte.
• Those skilled in the art will readily appreciate the compositions have wide utility in a number of assay formats.
• the signal generating component is used to perform Luminescent Oxygen Channeling Immunoassay (LOCITM) as described in EP-A2-0 515 194.
• LOCITM Luminescent Oxygen Channeling Immunoassay
• at least one specific binding partner is bound to a carrier according to the present invention.
• a medium suspected of containing an analyte is treated under conditions such the analyte affects the amount of a sensitizer capable in its excited state of generating singlet oxygen and a chemiluminescent compound that can come into close proximity such that singlet oxygen generated by said photosensitizer can activate said chemiluminescent compound, which subsequently produces light, and measuring the light, the amount thereof being related to the amount of analyte in said medium.
• the LOCITM method includes the steps of: (A) combining either simultaneously or wholly or partially sequentially (i) a medium suspected of containing the analyte; (ii) a first specific binding partner associated with a sensitizer capable in its excited state of generating singlet oxygen; and (iii) a second specific binding partner associated with a composition comprising a chemiluminescent compound, which is a substance that undergoes a chemical reaction with singlet oxygen to form a metastabile intermediate species that can decompose with the simultaneous or subsequent emission of light; (B) allowing the formation of complexes comprising the first and the second specific binding partner, the complex formation brings the sensitizer into close proximity to the chemiluminescent compound, (C) activating the sensitizer to generate singlet oxygen; and measuring the amount of light emitted by the chemiluminescent compound, the light is directly or inversely proportional to the amount of analyte in the medium.
• the composition comprising the chemiluminescent compound can also comprise one or more fluorescent molecules which are excited by the activated chemiluminescent compound.
• the light emitted by said fluorescent molecules can be measured to determine the amount of analyte in the medium.
• the carrier may be dyed both with a metal chelate and an oxygen acceptor.
• the oxygen acceptor is a component that reacts with singlet oxygen to form a highly unstable product that rapidly decomposes into an excited state. The excess energy of the excited state is transferred to the dye by a Forster energy transfer that takes place in a few nanoseconds.
• the metal chelate dye then emits a photon of light that can be detected with a photon counter.
• Suitable oxygen acceptors are disclosed in U.S. Pat. Nos. 5,578,498 and 5,811,311.
• One particularly preferred oxygen acceptor is C-28 thioxene, which has the following formula:
• the aminodextran coating is then applied as follows. 1mL of the dyed beads ( ⁇ 20mg/ml) is mixed with 20mg/ml of hydroxypropylaminodextran (MW 500K) in 0.05M MES / pH 6.0 in the presence of 3.8 mg/ml EDAC. After incubating this mixture for 16 hours at room temperature, (in the dark) the beads were washed once with 2ml of 0.05M MES / pH 6.0, then with 6ml of 0.05M MES, 1.0M NaCl/ pH 6.0. Finally the beads were resuspended in 1 ml of 0.05M MES / pH 6.0 to yield the coated beads. Washing was performed by centrifugation method (using Sorva) RC-5B Plus centifruge or Ependorf centrifuge-5415 C) and pellets were resuspended by sonication (using Branson Sonifer-450).
• the dextran aldehyde layer may then be added as follows. 1ml of the
• a first set of latex particles were dyed with Eu (NTA) 3 DPP and thioxene and coated with an aminodextran according to the methods described herein.
• a second set of latex particles were dyed with Eu (NHA) 3 DPP and thioxene and coated with an aminodextran.
• the aminodextran coating densities and the chemiluminesence were simultaneously measured at several concentrations of the metal chelate.
• the aminodextran coating density was measured by a colorimetric test after being treated with anthrone and 80% sulfuric acid.
• the chemiluminescence was measured as LOCI counts by a Envision-Alpha reader sold by Perkin-Elmer.
• the data points for Eu (NTA) 3 DPP are tabulated in Table 1 and shown graphically with curve fitting in FIG. 3.
• the data points for Eu(NHA) 3 DPP are tabulated in Table 2 and, for concentrations up to 0.094, are shown graphically with curve fitting in FIG. 4.
• Table 1 LOCI counts and aminodextran concentration as a function of europium concentration in E (NTA ⁇ DPP
• Table 2 LOCI counts and aminodextran concentration as a function of europium concentration in Eu (BHHT) 2 DPP
• the compound according to the present invention begins to plateau both in terms of aminodextran concentration and LOCI signal with as little as 0.065um Eu / gram of beads.
• the average aminodextran coating concentration is 49 ⁇ g/mg beads.
• the concentration of aminodextran generally holds steady as the concentration of europium is increased.
• Latex beads from Seradyn were dyed with 0.171 mmo! of Europium dye and 0.303 mmol of C-28 thioxene per gram of bead for each of two conventional dyes, Eu(TTA) 3 DPP and Eu(NTA) 3 DPP and two dyes according to the present invention, Eu(BHHT) 2 DPP and Eu(NHA) 3 DPP.
• the beads were then coated with aminodextran as described herein. The densities of the aminodextran was then determined, as well as the amplitude of its response signal. The data are tabulated on Table 3.

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Urology & Nephrology (AREA)
• Biomedical Technology (AREA)
• Hematology (AREA)
• Immunology (AREA)
• Chemical & Material Sciences (AREA)
• Molecular Biology (AREA)
• Cell Biology (AREA)
• Food Science & Technology (AREA)
• General Health & Medical Sciences (AREA)
• Biotechnology (AREA)
• Medicinal Chemistry (AREA)
• Physics & Mathematics (AREA)
• Analytical Chemistry (AREA)
• Biochemistry (AREA)
• Microbiology (AREA)
• General Physics & Mathematics (AREA)
• Pathology (AREA)
• Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
• Catalysts (AREA)
• Inorganic Compounds Of Heavy Metals (AREA)
• Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)

Priority Applications (3)

Applications Claiming Priority (2)

Publications (2)

Family

ID=36692776

Family Applications (1)

Country Status (6)

Cited By (5)

Families Citing this family (3)

Family Cites Families (29)

• 2005
  • 2005-01-21 US US11/040,887 patent/US20060166376A1/en not_active Abandoned
• 2006
  • 2006-01-17 EP EP06718583A patent/EP1856529B1/en active Active
  • 2006-01-17 PT PT06718583T patent/PT1856529E/pt unknown
  • 2006-01-17 ES ES06718583T patent/ES2392730T3/es active Active
  • 2006-01-17 WO PCT/US2006/001529 patent/WO2006078618A2/en active Application Filing
  • 2006-01-17 JP JP2007552204A patent/JP4741607B2/ja active Active
  • 2006-08-04 US US11/499,519 patent/US7691647B2/en active Active
• 2009
  • 2009-09-08 US US12/555,734 patent/US20090325316A1/en not_active Abandoned

Non-Patent Citations (2)

Also Published As

Similar Documents

Legal Events